← Back to Search

Micro-Interaction Ecological Momentary Assessment (µEMA) for Aphasia

N/A
Waitlist Available
Led By Erin L Meier, PhD
Research Sponsored by Northeastern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up every day over the three-week at-home smartwatch naming protocol
Awards & highlights

Study Summary

This trial studies whether using a smartwatch to measure anomia (inability to find words) in people with post-stroke aphasia can help them communicate better in everyday life.

Eligible Conditions
  • Aphasia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~every day over the three-week at-home smartwatch naming protocol
This trial's timeline: 3 weeks for screening, Varies for treatment, and every day over the three-week at-home smartwatch naming protocol for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Audio Intelligibility
Change in Protocol Completion
Change in Protocol Compliance
Secondary outcome measures
Change in Perceived Burden

Trial Design

2Treatment groups
Experimental Treatment
Group I: Traditional Ecological Momentary Assessment (Traditional EMA)Experimental Treatment1 Intervention
People with aphasia (PWA) in the traditional EMA arm will receive four prompts per day to complete a set of nine picture naming trials per prompt for a total of n = 36 prompts/day for three weeks.
Group II: Micro-Interaction Ecological Momentary Assessment (µEMA)Experimental Treatment1 Intervention
People with aphasia (PWA) in the µEMA condition will complete a single naming trial at a time, 36 times per day for three weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Micro-Interaction EMA
2022
N/A
~20
Traditional EMA
2022
N/A
~20

Find a Location

Who is running the clinical trial?

Northeastern UniversityLead Sponsor
87 Previous Clinical Trials
59,544 Total Patients Enrolled
National Center for Advancing Translational Science (NCATS)NIH
99 Previous Clinical Trials
36,293 Total Patients Enrolled
1 Trials studying Aphasia
1,489 Patients Enrolled for Aphasia
National Center for Advancing Translational Sciences (NCATS)NIH
320 Previous Clinical Trials
401,714 Total Patients Enrolled
2 Trials studying Aphasia
1,504 Patients Enrolled for Aphasia

Media Library

Micro-Interaction EMA Clinical Trial Eligibility Overview. Trial Name: NCT05338216 — N/A
Aphasia Research Study Groups: Micro-Interaction Ecological Momentary Assessment (µEMA), Traditional Ecological Momentary Assessment (Traditional EMA)
Aphasia Clinical Trial 2023: Micro-Interaction EMA Highlights & Side Effects. Trial Name: NCT05338216 — N/A
Micro-Interaction EMA 2023 Treatment Timeline for Medical Study. Trial Name: NCT05338216 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many subjects is this experiment accommodating?

"Affirmative. According to clinicaltrials.gov information, this clinical trial is in search of participants at the present time. The first posting occurred on December 19th 2022 and was recently revised April 20th 2023. This particular trial requires recruitment of twenty patients from a single site."

Answered by AI

Are there any vacancies for participant recruitment in this research endeavor?

"Affirmative, according to clinicaltrials.gov, this medical research study is presently seeking volunteers and was initially posted on December 19th 2022. The last edit was made April 20th 2023 with the current need for twenty participants across a single site."

Answered by AI

Who meets the eligibility requirements for this research project?

"This research project is recruiting 20 people with aphasia, aged 18 to 89. These participants must have had left hemisphere stroke for at least 6 months and possess current/pre-stroke English proficiency, normal or corrected vision and hearing, medical stability and signs of aphasia."

Answered by AI

Does this trial encompass individuals aged fifty or above?

"Patient eligibility is contingent upon being between 18 and 89 years old."

Answered by AI
~7 spots leftby Apr 2025